Filter
198
Filtered Results: 198
Text search:
counterfeit
drug
Featured
Recommendations
13
New Publications
71
Language
Document type
No document type
106
Studies & Reports
40
Guidelines
29
Manuals
9
Strategic & Response Plan
6
Situation Updates
3
Fact sheets
3
Training Material
2
Countries / Regions
Kenya
12
Uganda
11
Ghana
7
Nigeria
7
Ethiopia
7
Tanzania
6
Zimbabwe
5
Cambodia
5
Liberia
5
Sierra Leone
4
Botswana
4
Zambia
4
Myanmar / Burma
4
Rwanda
3
South–East Asia Region
3
Bangladesh
3
South Africa
3
Eswatini/ Swaziland
3
Nepal
2
Ukraine
2
Cameroon
2
Senegal
2
Malawi
2
Philippines
2
Global
2
Africa
2
Namibia
2
Thailand
1
Lesotho
1
China
1
Laos
1
Burkina Faso
1
Mozambique
1
Haiti
1
Asia
1
Congo, Democratic Republic of
1
Vietnam
1
Moldova
1
Sri Lanka
1
Central African Republic
1
Indonesia
1
Somalia
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
50
Policies
31
Guidelines
17
Studies & Reports
13
Laboratory Quality Assurance
5
Malaria
4
Digital Health
3
Countries
3
Statistics
3
General Guidelines
3
Disease Prevention & Control
3
Vector Control
2
Policies & Guidelines HIV & TB
2
Capacity Building
2
Health Systems
2
Paediatrics
1
Family Planning
1
Humanitarian Aid
1
Monitoring & Evaluation
1
Cancer Treatment & Resources
1
Sex. & Repr. Rights
1
Pediatrics
1
Pharmaceutical Assessments
1
Health System Strengthening
1
Demograhic Health Surveys DHS
1
Women & Child Health
1
Community Health
1
Disabilities
1
Other
1
Needs Assessment
1
Protection & Security
1
Primary Health Care
1
Neurology & Psychology
1
Non-communicable Diseases
1
HIV & STI
1
Global Health
1
Pharmacy & Technologies
1
Toolboxes
Falsified & Substandard
13
Country specific
8
Quality Assurance
7
Rational use of Medicine
7
Country Specific
6
Supply Chain & Store Management
6
Substance Use Disorders & Addiction
5
Pharmacovigilance
4
Substance Use Disorders, Others
3
Policies
3
International
3
Pharmacy Practice
3
Reports & Studies
3
Assessment
3
Public Health
2
Cannabis
2
Supporting tools
2
Studies
2
Health Personnel
2
General
2
Livestock production
2
Logistics & Supply
2
Primary Care
2
Universal Health Coverage & Primary Health Care
2
Cocaine
1
Agriculture & Veterinary
1
Key Resources
1
Policies & Programmes
1
Clinical Guidelines
1
Diverse Chemical Substances
1
General Studies & Reports
1
Children/Adolescents Mental Disorders
1
Attention deficit hyperactivity disorder (ADHD)
1
Sustainable Development Goals
1
Climate & Health
1
Diagnostics & Laboratory Guidance
1
Clinical Guidelines
1
Guidelines
1
Sustainability
1
Essential Medicines & Medical Devices
1
Extreme Situations
1
Advocacy & Communication
1
Essential Medicines
1
Pharmaceutical Assessments
1
Standard Operating Procedures (SOPs)
1
Traditional & Herbal Medicines
1
Strategies
1
Agriculture incl. animal husbandry
1
Epilepsy
1
Mental Disorders
1
Situation Reports & Updates
1
Zoonoses
1
Health Care In Conflict Settings
1
Humanitarian Aid Guidelines
1
Studies & Reports
1
Protection
1
Research & Access
1
Disaster Preparedness & Prevention
1
Uganda
1
Stewardship
1
General Public
1
TB/HIV Coinfection
1
Planetary Health
1
SEAR (South-east Asia Region)
1
Communication & Training
1
Global Burden of Disease
1
Preparedness & Prevention
1
Bull World Health Organ 2017;95:594–598
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
The classification of digital health interventions (DHIs) categorizes the different ways in which digital and mobile technologies are being used to support health system needs. Historically, the diverse communities working in digital health—including government stakeholders, technologists, clinic...
For the Fiscal Year 2015-2016, the Health Sector continued to implement actions meant to improve the availability, and access to quality healthcare. The following report highlights achievements registered by the health sector for the fiscal 2015-2016 in different health programs, as well as in the a...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Act 851 | AN ACT to revise and consolidate the law relating to public health to
prevent disease, promote, safeguard, maintain and protect the health
of humans and animals and to provide for related matters.
This FY 2019 Malaria Operational Plan presents a detailed implementation plan for Burkina Faso, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the NMCP and with the participation of national and international partners involved in...
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis...
2014-2020, Draft March 2014
